298 related articles for article (PubMed ID: 34664087)
1. The microbiome and IgA nephropathy.
Haniuda K; Gommerman JL; Reich HN
Semin Immunopathol; 2021 Oct; 43(5):649-656. PubMed ID: 34664087
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.
He JW; Zhou XJ; Lv JC; Zhang H
Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226
[TBL] [Abstract][Full Text] [Related]
3. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
[TBL] [Abstract][Full Text] [Related]
4. Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy.
Yamaguchi H; Goto S; Takahashi N; Tsuchida M; Watanabe H; Yamamoto S; Kaneko Y; Higashi K; Mori H; Nakamura Y; Horii A; Kurokawa K; Narita I
Nephrol Dial Transplant; 2021 Jan; 36(1):75-86. PubMed ID: 33099625
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses.
Currie EG; Coburn B; Porfilio EA; Lam P; Rojas OL; Novak J; Yang S; Chowdhury RB; Ward LA; Wang PW; Khaleghi K; An J; Crome SQ; Hladunewich MA; Barbour SJ; Cattran DC; Parekh RS; Licht C; John R; Kaul R; Croitoru K; Gray-Owen SD; Guttman DS; Gommerman JL; Reich HN
JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35133979
[TBL] [Abstract][Full Text] [Related]
6. The mucosal immune system and IgA nephropathy.
Gesualdo L; Di Leo V; Coppo R
Semin Immunopathol; 2021 Oct; 43(5):657-668. PubMed ID: 34642783
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome.
Harabuchi Y; Takahara M
Immun Inflamm Dis; 2019 Jun; 7(2):86-93. PubMed ID: 30957421
[TBL] [Abstract][Full Text] [Related]
8. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
Lauriero G; Abbad L; Vacca M; Celano G; Chemouny JM; Calasso M; Berthelot L; Gesualdo L; De Angelis M; Monteiro RC
Front Immunol; 2021; 12():694787. PubMed ID: 34712223
[TBL] [Abstract][Full Text] [Related]
10. The immune landscape of IgA induction in the gut.
Seikrit C; Pabst O
Semin Immunopathol; 2021 Oct; 43(5):627-637. PubMed ID: 34379174
[TBL] [Abstract][Full Text] [Related]
11. The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.
Coppo R
Pediatr Nephrol; 2018 Jan; 33(1):53-61. PubMed ID: 28389744
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes.
Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z
Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195
[TBL] [Abstract][Full Text] [Related]
13. The Gut-Renal Connection in IgA Nephropathy.
Coppo R
Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
[TBL] [Abstract][Full Text] [Related]
14. The mucosa-kidney axis in IgA nephropathy.
Floege J; Feehally J
Nat Rev Nephrol; 2016 Mar; 12(3):147-56. PubMed ID: 26714580
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
[TBL] [Abstract][Full Text] [Related]
16. [Haemophilus parainfluenzae antigens in IgA nephropathy].
Suzuki S; Kimura H; Gejyo F
Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
[TBL] [Abstract][Full Text] [Related]
17. Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease.
Hu X; Fan R; Song W; Qing J; Yan X; Li Y; Duan Q; Li Y
Front Cell Infect Microbiol; 2022; 12():1061629. PubMed ID: 36590596
[TBL] [Abstract][Full Text] [Related]
18. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.
Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS
Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies.
Han S; Shang L; Lu Y; Wang Y
Front Cell Infect Microbiol; 2022; 12():904401. PubMed ID: 35656030
[TBL] [Abstract][Full Text] [Related]
20. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
